Cargando…

Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders

Synaptopathies are brain disorders characterized by dysfunctional synapses, which are specialized junctions between neurons that are essential for the transmission of information. Synaptic dysfunction can occur due to mutations that alter the structure and function of synaptic components or abnormal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuttler, Katelyn, Hassan, Maryam, Carr, Jonathan, Cloete, Ruben, Bardien, Soraya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492176/ https://www.ncbi.nlm.nih.gov/pubmed/34610269 http://dx.doi.org/10.1098/rsob.210091

Ejemplares similares

Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology
por: Cuttler, Katelyn, et al.
Publicado: (2022)

Prioritization of candidate genes for a South African family with Parkinson’s disease using in-silico tools
por: Sebate, Boiketlo, et al.
Publicado: (2021)

Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders
por: Enogieru, Adaze Bijou, et al.
Publicado: (2018)

Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder
por: Khoja, Sheraz, et al.
Publicado: (2023)

The emerging role of furin in neurodegenerative and neuropsychiatric diseases
por: Zhang, Yi, et al.
Publicado: (2022)

Neurexins
por: Reissner, Carsten, et al.
Publicado: (2013)

Exosomes as Emerging Biomarker Tools in Neurodegenerative and Neuropsychiatric Disorders—A Proteomics Perspective
por: Mathew, Boby, et al.
Publicado: (2021)

Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders
por: Poppi, Lauren A., et al.
Publicado: (2021)

Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018)

Analysis methods for the gut microbiome in neuropsychiatric and neurodegenerative disorders
por: Song, Jae Gwang, et al.
Publicado: (2022)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

Neurexin-2: An inhibitory neurexin that restricts excitatory synapse formation in the hippocampus
por: Lin, Pei-Yi, et al.
Publicado: (2023)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function
por: Kapustin, Daniel, et al.
Publicado: (2023)

Emerging Roles of FTO in Neuropsychiatric Disorders
por: Chang, Rui, et al.
Publicado: (2022)

Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
por: Diniz, Breno Satler, et al.
Publicado: (2013)

Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization
por: Naito, Yusuke, et al.
Publicado: (2017)

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021)

Neurexins and their ligands at inhibitory synapses
por: Boxer, Emma E., et al.
Publicado: (2022)

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry
por: Camporesi, Elena, et al.
Publicado: (2022)

Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases
por: Reynolds, Regina H., et al.
Publicado: (2023)

Heterozygous Deletion of α-Neurexin I or α-Neurexin II Results in Behaviors Relevant to Autism and Schizophrenia
por: Dachtler, James, et al.
Publicado: (2015)

α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization
por: Feller, Benjamin, et al.
Publicado: (2023)

Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders
por: Peng, Shichun, et al.
Publicado: (2021)

Implant survival in patients with neuropsychiatric, neurocognitive, and neurodegenerative disorders: A meta-analysis
por: Bera, Rathindra Nath, et al.
Publicado: (2021)

Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
por: Cummings, Jeffrey, et al.
Publicado: (2019)

The role of hand preference in cognition and neuropsychiatric symptoms in neurodegenerative diseases
por: Saari, Toni T, et al.
Publicado: (2023)

Deciphering the Function of Neurexins at Cellular Junctions
por: Littleton, J. Troy, et al.
Publicado: (1997)

Neurexin in Embryonic Drosophila Neuromuscular Junctions
por: Chen, Kaiyun, et al.
Publicado: (2010)

Translational Inhibition of α-Neurexin 2
por: Ding, Xiaoting, et al.
Publicado: (2020)

Structure, function, and pathology of Neurexin-3
por: Zhang, Rui, et al.
Publicado: (2022)

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
por: Sałaciak, Kinga, et al.
Publicado: (2021)

Neurexin-3 subsynaptic densities are spatially distinct from Neurexin-1 and essential for excitatory synapse nanoscale organization in the hippocampus
por: Lloyd, Brian A, et al.
Publicado: (2023)

Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases
por: Paul, Bindu D., et al.
Publicado: (2019)

Neurotrophin Crosstalk in the Etiology and Treatment of Neuropsychiatric and Neurodegenerative Disease
por: Joshi, Rajeev, et al.
Publicado: (2022)

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
por: McGrath, Thomas, et al.
Publicado: (2022)

Molecular Dynamic Simulation of Neurexin1α Mutations Associated with Mental Disorder
por: Hendam, Ashraf, et al.
Publicado: (2022)

The Many Faces of Stress: Implications for Neuropsychiatric Disorders
por: Musazzi, Laura, et al.
Publicado: (2016)

Endoplasmic Reticulum Stress: Implications for Neuropsychiatric Disorders
por: Muneer, Ather, et al.
Publicado: (2019)

Deletions of NRXN1 (Neurexin-1) Predispose to a Wide Spectrum of Developmental Disorders
por: Ching, Michael SL, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_klv87o5mqjjrvav3qq6kegihn0